Tag: CorVista

CorVista Health and ATSS Sign Memorandum of Understanding to Bring Point-of-Care Cardiovascular Diagnostic Platform CorVista® System to the Kingdom of Saudi Arabia

Coronary/Structural Heart by Comments are Disabled

BETHESDA, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) — CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, today announced the signing of a Memorandum of Understanding (MOU) with Advanced Telecommunications Solutions and Services (ATSS) to explore the potential of introducing the CorVista® System into the Kingdom of Saudi Arabia. The CorVista System is the world’s first point-of-care system for evaluating the presence of significant coronary artery disease (CAD) and pulmonary hypertension (PH) in a single visit.

Continue Reading →

Analytics for Life and CorVista Health Announce the Publication of their Cost Economic Analysis for Non-Invasive Coronary Artery Disease Testing in the Journal of Visualized Experiments

Coronary/Structural Heart by 0 comments

TORONTO & BETHESDA, Md.–(BUSINESS WIRE)–Today, Analytics for Life, a leading innovator in advanced point-of-care diagnostics, and CorVista Health, pioneers in non-invasive cardiac diagnostics, announced a publication of a new comprehensive cost economic analysis of their non-invasive point-of-care test for Coronary Artery Disease (CAD) in the Journal of Visualized Experiments (JoVE). “We believe our innovative approach to […]

Continue Reading →

CorVista Health to Present New Data on the Use of Machine Learning as a Non-Invasive Point-of-Care Rule-out Test for Heart Failure at ACC 2024

Coronary/Structural Heart by 0 comments

New data support the feasibility of machine learned algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP) Data collected using the CorVista System®, the world’s first non-invasive point-of-care solution approved for evaluating the presence of coronary artery disease and pulmonary hypertension April 07, 2024 09:00 AM Eastern Daylight Time BETHESDA, Md.–(BUSINESS WIRE)–CorVista Health, Inc., a […]

Continue Reading →

CorVista Health Announces Anjali Tiku Owens, M.D. Appointment to Medical Advisory Board

Financial by Comments are Disabled

BETHESDA, Md.–(BUSINESS WIRE)–CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis announces expansion of their Medical Advisory Board with the appointment of Dr. Anjali Tiku Owens. “Dr. Tiku Owens’ wealth of experience and expertise in cardiology, particularly in genetic cardiomyopathy and novel therapies, will be invaluable as we work to […]

Continue Reading →

CorVista Health Named MedTech Outlook Editor’s Choice for MedTech Startup for 2023

Financial by 0 comments

WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce that it has been honored with the Editor’s Choice designation as the Top MedTech Startup for 2023 by MedTech Outlook. “We are glad to feature CorVista Health as the Editor’s Choice and one of the Top […]

Continue Reading →

CorVista Health Announces FDA Clearance of the Novel CorVista System to Detect the Presence of Cardiac Disease

Coronary/Structural Heart by 0 comments

WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the FDA clearance of the CorVista System® with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis. “CorVista Health’s innovative solution has the potential to make a tremendous impact […]

Continue Reading →

CorVista Health Welcomes Dr. Tim Attebery as New Board Member

Financial by 0 comments

WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the election of Dr. Tim Attebery to its Board of Directors. “Our shareholders, along with the leadership team of CorVista Health, are thrilled to have Tim join our Board of Directors” Tweet this As the company […]

Continue Reading →

The CorVista® Analysis provides a supervised machine-learned algorithm to IDENTIFY PH patients with New Onset Symptoms

Coronary/Structural Heart by 0 comments

IDENTIFY PH presented at ATS WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, announces the presentation of a machine-learned algorithm to IDENTIFY PH at the American Thoracic Society (ATS) conference. This proof of concept showcases the effectiveness of a machine learned (ML) phase space electro-mechanical pulse wave analysis […]

Continue Reading →

The CorVista® Analysis Provides a Robust Prediction for Elevated Left Ventricular End Diastolic Pressure at the Point-Of-Care

Coronary/Structural Heart by 0 comments

IDENTIFY Study Results Published in PLOS ONE WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces the publishing of the IDENTIFY Study in PLOS ONE, the multicenter validation of a machine learned (ML) phase space electro-mechanical pulse wave analysis to predict elevated left ventricular end diastolic pressure (LVEDP) at the […]

Continue Reading →

CorVista Health Receives Breakthrough Device Designation for The CorVista® System

Coronary/Structural Heart Regulatory by 0 comments

WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CorVista System as a first non-invasive point of care diagnostic solution for patients with suspected pulmonary hypertension. The FDA’s Breakthrough Devices Program is a voluntary […]

Continue Reading →
1 2